BX Swiss TOP 30 CHF
1.373,23
PKT
+13,12
PKT
+0,96
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.05.16 | Zurich Insurance Halten | DZ-Bank AG | |
| 12.05.16 | Nestlé overweight | JP Morgan Chase & Co. | |
| 12.05.16 | Richemont Outperform | Bernstein Research | |
| 12.05.16 | UBS Underperform | BNP PARIBAS | |
| 11.05.16 | Holcim buy | Kepler Cheuvreux | |
| 11.05.16 | Novartis buy | Jefferies & Company Inc. | |
| 11.05.16 | Roche buy | Jefferies & Company Inc. | |
| 11.05.16 | UBS Equal-Weight | Morgan Stanley | |
| 11.05.16 | UBS buy | Citigroup Corp. | |
| 11.05.16 | UBS Neutral | JP Morgan Chase & Co. | |
| 11.05.16 | Richemont overweight | JP Morgan Chase & Co. | |
| 10.05.16 | Nestlé overweight | Morgan Stanley | |
| 10.05.16 | Nestlé Neutral | UBS AG | |
| 09.05.16 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 09.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 06.05.16 | Richemont buy | HSBC | |
| 06.05.16 | Richemont buy | Goldman Sachs Group Inc. | |
| 05.05.16 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 04.05.16 | UBS Sector Perform | Robert W. Baird & Co. Incorporated | |
| 04.05.16 | UBS Halten | Independent Research GmbH | |
| 04.05.16 | UBS Equal-Weight | Morgan Stanley | |
| 04.05.16 | UBS Neutral | JP Morgan Chase & Co. | |
| 04.05.16 | Holcim Neutral | UBS AG | |
| 04.05.16 | Swiss Re market-perform | Bernstein Research | |
| 04.05.16 | UBS Neutral | Credit Suisse Group | |
| 03.05.16 | Holcim buy | Jefferies & Company Inc. | |
| 03.05.16 | UBS Underperform | Merrill Lynch & Co., Inc. | |
| 03.05.16 | UBS buy | Citigroup Corp. | |
| 03.05.16 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 03.05.16 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 03.05.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 29.04.16 | Swiss Re kaufen | DZ-Bank AG | |
| 28.04.16 | Richemont Outperform | Robert W. Baird & Co. Incorporated | |
| 28.04.16 | Novartis Neutral | UBS AG | |
| 27.04.16 | Nestlé Outperform | Robert W. Baird & Co. Incorporated | |
| 27.04.16 | Holcim Neutral | JP Morgan Chase & Co. | |
| 27.04.16 | UBS buy | Goldman Sachs Group Inc. | |
| 27.04.16 | UBS Neutral | Goldman Sachs Group Inc. | |
| 26.04.16 | Novartis Outperform | Bernstein Research | |
| 26.04.16 | Roche Outperform | Bernstein Research |